Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Clinical Developments in Renal Cell Carcinoma
EP. 1: Introduction and Review of the COMPARZ Trial in RCC
July 1st 2013
EP. 2: COMPARZ Trial and Alternate Sunitinib Dosing Schedule
July 1st 2013
EP. 3: PISCES Trial and Patient Treatment Preference in mRCC
July 1st 2013
EP. 4: AGILE Trial: Frontline Axitinib Versus Sorafenib in mRCC
July 1st 2013
EP. 5: Utilizing Frontline Bevacizumab in mRCC
July 1st 2013
EP. 6: Frontline Sunitinib Compared to Everolimus in mRCC
July 1st 2013
EP. 7: AXIS Trial: Second-Line Axitinib Versus Sorafenib
July 1st 2013
EP. 8: Determining Progression in Renal Cell Carcinoma
July 1st 2013
EP. 9: INTORSECT Trial: Second-Line Temsirolimus Versus Sorafenib
July 1st 2013
EP. 10: Novel Agents in Development for Renal Cell Carcinoma
July 1st 2013
EP. 11: Immune Checkpoint Inhibition in Renal Cell Carcinoma
July 1st 2013
EP. 12: Unmet Needs in Renal Cell Carcinoma
July 1st 2013
EP. 13: Conclusion: Key Take-Away Points and Cardiac Safety
July 1st 2013